Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
6.55
↑ 131% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-21.09
Historical baseline
PeriodValueYoY Change
20256.55+596.3%
2024-1.32-22.6%
2023-1.08-68.3%
2022-0.64+47.9%
2021-1.23+92.0%
2020-15.44+64.2%
2019-43.13+31.5%
2018-63.00+10.6%
2017-70.49-